Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Abbott Laboratories Inc. convinced a federal judge that there wasn’t a feasible alternative design to a form of infant formula that parents said caused a fatal disease to their preterm child.

Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...